Taiwan is rolling out artificial intelligence agent systems across its major hospital networks, with technology manufacturer Foxconn acting as ecosystem integrator and NVIDIA providing the underlying infrastructure.
The deployments are taking place under the government’s Healthy Taiwan initiative, which has committed $1.5 billion to building a nationally governed, AI-native health system. The programme spans clinical hospitals, academic institutions and technology companies, with the aim of scaling clinical capacity against the pressures of one of the world’s fastest-ageing populations.
Foxconn’s CoDoctor platform coordinates teams of specialised AI agents focused on areas including cardiovascular care, oncology and ophthalmology. New agents within the platform include an ECG screening system for cardiac triage, a tool that reconstructs the heart and coronary arteries in 3D — reducing a two-hour workflow to approximately one minute — and a colonoscopy assistance system capable of real-time lesion detection at the surgical edge. These systems run on NVIDIA’s Nemotron open models.
Foxconn has also introduced CoDoClaw, a multi-agent orchestration platform built on NVIDIA’s NemoClaw blueprint, which coordinates agents across breast cancer screening, ECG analysis, fundus imaging and coronary artery analysis through a unified clinical interface.
On the physical side, Foxconn’s Nurabot nursing collaborative robot — powered by NVIDIA’s physical AI stack — has moved beyond a pilot at Taichung Veterans General Hospital and is being introduced to additional sites including Taipei Veterans General Hospital and Tungs’ Taichung MetroHarbor Hospital.
The robot handles transport and logistics tasks, estimated to free two to three hours per day for frontline nursing staff. A new surgical assistant robot, Scrub Bot, has been developed for use in live operating theatres, responding to voice commands from surgeons in real time.
Prior to physical deployment, Foxconn uses NVIDIA Omniverse-powered digital twins of hospital facilities to test and validate AI and robotic systems. The simulation-first approach has reportedly reduced deployment time by 40% and achieved 98% navigation accuracy.
Active AI deployments now span Chang Gung Memorial Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital, MacKay Memorial Hospital, National Taiwan University Hospital and several other major care sites, collectively handling more than 14 million patient encounters annually. Taiwan currently holds 85 FDA- or TFDA-cleared medical AI solutions.
Discover more from HealthTechAsia
Subscribe to get the latest posts sent to your email.